Analysis of the Efficacy of Cardiac Ischemic Postconditioning With New Clinical End-points Using Novel Biomarkers
NCT ID: NCT04824716
Last Updated: 2021-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2013-01-14
2018-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocardial Infarction.
NCT03447834
Impact of Ischemic Post-conditioning
NCT04068116
Postconditioning in ST-elevation Myocardial Infarction
NCT00922675
Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia
NCT04685941
Study to Evaluate the Care Process and the Quality of STEMI Care
NCT02961777
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Characterisation of postconditioning is performed by the following parameters:
1. Blood tests 5 minutes before as well as 8, 60 minutes, 24 hours, and 3 months after PCI to measure nitrotyrosine, a biomarker of peroxynitrite formation (nitrosative stress) by ELISA; B-type natriuretic peptide, a biomarker of heart failure by ELISA; matrix metalloproteinase activities (MMP-2 and MMP-9) putative biomarkers of cardiac remodelling by zymography; microRNA expression pattern by sequencing and its validation by quantitative real-time polymerase chain reaction (PCR).
2. Routine laboratory tests 6, 12 and 48 hours after PCI including creatine kinase (CKMB) and cardiac troponin T (cTnT).
3. ECG immediately after recanalization and intervention after 60 and 90 minutes, then 12, 24, 36 and 48 hours later 12-lead ECG is registered.
4. Echocardiography: 48 hours after intervention, standard view to judge left ventricle segments movement disorders
5. Angiography: Blush, Syntax score, and ischemic risk zone (area at risk, AAR) are determined
6. cardiac late enhancement magnetic resonance (MR) imaging to determine infarct size
At 3-month follow-up visit the following parameters were measured: echocardiography for restitution assessment, cardiac late enhancement MR imaging to determine infarct size and cardiac function, blood sampling for above mentioned biochemical laboratory tests
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
postconditioning
Patients that underwent postconditioning after primary percutaneous coronary intervention.
Postconditioning
The protocol of primary PCI followed by stenting is executed according to the descriptions according to the majority of relevant scientific literature on postconditioning studies and in accordance with the most recent guidelines. In the post conditioned group, after recanalization, the artery is occluded by inflation of stent balloon (4 times for 1-1 minute) followed by 1-1-minute reperfusion, repeatedly. Eight minutes after the start of examination, angiography is made in order to determine blood flow. Intervention is finished by the operator and another angiographic image is made (identical to initial standard projection).
control
Patients that underwent primary percutaneous coronary intervention.
Percutaneous coronary intervention
Percutaneous coronary intervention as per European Society of Cardiology guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Postconditioning
The protocol of primary PCI followed by stenting is executed according to the descriptions according to the majority of relevant scientific literature on postconditioning studies and in accordance with the most recent guidelines. In the post conditioned group, after recanalization, the artery is occluded by inflation of stent balloon (4 times for 1-1 minute) followed by 1-1-minute reperfusion, repeatedly. Eight minutes after the start of examination, angiography is made in order to determine blood flow. Intervention is finished by the operator and another angiographic image is made (identical to initial standard projection).
Percutaneous coronary intervention
Percutaneous coronary intervention as per European Society of Cardiology guidelines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Myocardial infarction with elevated ST
3. Chest pain onset less than 12 hours before PCI
4. concordant ST elevation (\>0,1 mV) in at least 2 ECG leads
5. Occluded main proximal or middle main coronary ('Thrombolysis In Myocardial Infarction' flow grade: 0) diagnosed with coronarography
6. Coronary opened by PCI (TIMI 2 flow grade)
7. Awake, conscious, co-operating patient, who is able to retain his breath for 10 sec
8. Signed Patient Information Leaflet and Patient Informed Consent Form
Exclusion Criteria
2. Previous myocardial infarction in the area of the occluded coronary artery
3. Occluded coronary with visible collateral branches
4. Lack of co-operation
5. Current left or right bundle branch block (LBBB)
6. Malignant ventricle arrhythmia or atrial fibrillation
7. Killip class \> 2
8. Known renal failure
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Semmelweis University Heart and Vascular Center
OTHER
Szeged University
OTHER
Peter Ferdinandy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Ferdinandy
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Béla Merkely, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Heart and Vascular Center, Semmelweis University, Budapest
Peter Ferdinandy, MD, PhD, MBA
Role: STUDY_DIRECTOR
Pharmahungary Group
Imre Ungi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Szeged, Faculty of Medicine, Cardiology Center, Department of Invasive Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart and Vascular Center, Semmelweis University
Budapest, , Hungary
Pharmahungary Group
Szeged, , Hungary
Department of Invasive Cardiology of Cardiology Center, Faculty of Medicine, University of Szeged
Szeged, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website of Pharmahungary Group.
Website of Semmelweis University Heart and Vascular Center.
Website of Department of Invasive Cardiology of Cardiology Center, Faculty of Medicine, University of Szeged.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPOST-01, v2.0, Nov 22, 2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.